TW240168B - - Google Patents
Info
- Publication number
- TW240168B TW240168B TW082106642A TW82106642A TW240168B TW 240168 B TW240168 B TW 240168B TW 082106642 A TW082106642 A TW 082106642A TW 82106642 A TW82106642 A TW 82106642A TW 240168 B TW240168 B TW 240168B
- Authority
- TW
- Taiwan
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22037392 | 1992-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW240168B true TW240168B (OSRAM) | 1995-02-11 |
Family
ID=16750110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082106642A TW240168B (OSRAM) | 1992-08-19 | 1993-08-18 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5464833A (OSRAM) |
| EP (1) | EP0623598A4 (OSRAM) |
| AU (1) | AU666577B2 (OSRAM) |
| CA (1) | CA2121148A1 (OSRAM) |
| MX (1) | MX9305056A (OSRAM) |
| PH (1) | PH30152A (OSRAM) |
| TW (1) | TW240168B (OSRAM) |
| WO (1) | WO1994004504A1 (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2134880A1 (en) * | 1993-03-02 | 1994-09-03 | Akira Matsumori | Graft rejection inhibitor and il-1 production inhibitor |
| US5497913A (en) * | 1993-12-15 | 1996-03-12 | Denny D. Baker | Mixing bag arrangement and method |
| EP0711356A4 (en) * | 1994-05-26 | 1999-11-24 | New York Medical College | DETECTION OF HALOGEN PRECURSORS INCORPORATED IN DNA |
| US5504093A (en) * | 1994-08-01 | 1996-04-02 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication |
| CA2158822C (en) * | 1994-09-27 | 2008-12-23 | Kusuki Nishioka | Therapeutic agent for rheumatic disease |
| US5620888A (en) * | 1994-12-29 | 1997-04-15 | Lxr Biotechnology, Inc. | Cell strains for use in identifying potentially therapeutically effective agents |
| US5571523A (en) * | 1995-03-09 | 1996-11-05 | President And Fellows Of Harvard College | Antioxidant-induced apoptosis in vascular smooth muscle cells |
| WO1998046229A1 (en) * | 1995-06-21 | 1998-10-22 | Otsuka Pharmaceutical Co., Ltd. | Il-8 and mcaf production inhibitors |
| EP0851939A4 (en) * | 1995-08-30 | 2001-02-28 | New York Medical College | METHOD FOR MARKING DNA ENDS WITH HALOGENATED NUCLEOTIDES AND DETECTING THEM WITH ANTIBODIES |
| US5846758A (en) * | 1995-11-30 | 1998-12-08 | His Excellency Ghassan I. Shaker | Method for diagnosing autoimmune diseases |
| WO1997031910A1 (en) * | 1996-02-28 | 1997-09-04 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5780480A (en) * | 1996-02-28 | 1998-07-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US20020151063A1 (en) * | 1996-08-30 | 2002-10-17 | Annette Lasham | Methods for modulating apoptotic cell death |
| US5912168A (en) * | 1996-08-30 | 1999-06-15 | Genesis Research & Development Corporation Limited | CD95 regulatory gene sequences |
| US6180402B1 (en) | 1996-11-20 | 2001-01-30 | Qlt Inc. | Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor |
| WO1998048807A1 (en) * | 1997-04-25 | 1998-11-05 | Otsuka Pharmaceutical Co., Ltd. | Hyaluronate synthesis inhibitors |
| TWI244484B (en) * | 1998-06-09 | 2005-12-01 | Takara Bio Inc | Pharmaceutical composition containing oxy-containing hexacyclic compound |
| EP2311490A3 (en) | 1998-07-13 | 2011-05-04 | Board of Regents, The University of Texas System | Uses of antibodies to aminophospholipids for cancer treatment |
| EP1234585A3 (en) | 1998-09-04 | 2004-01-21 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| AU5877500A (en) * | 1999-06-15 | 2001-01-02 | Neurogen Corporation | Piperidinyl and piperazinyl substituted benzofused lactams |
| US6254888B1 (en) * | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
| EP1404329A4 (en) * | 2001-06-04 | 2006-11-02 | Cytovia Inc | QUINOLINONES 4-ARYL-3- (3-ARYL-1-OXO-2-PROPENYL) -2 (1H) -US SUBSTITUTED, AND ANALOGUES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS, AND RELATIVE USE |
| GB0124848D0 (en) | 2001-10-16 | 2001-12-05 | Celltech R&D Ltd | Chemical compounds |
| US7354928B2 (en) * | 2001-11-01 | 2008-04-08 | The Regents Of The University Of Michigan | Small molecule inhibitors targeted at Bcl-2 |
| US20040014744A1 (en) * | 2002-04-05 | 2004-01-22 | Fortuna Haviv | Substituted pyridines having antiangiogenic activity |
| EP2283868B1 (en) | 2002-07-15 | 2016-03-30 | Board of Regents, The University of Texas System | Peptides binding to phosphatidylethanolamine and their use in treating viral infections and cancer |
| KR101395370B1 (ko) | 2004-01-22 | 2014-05-14 | 유니버시티 오브 마이애미 | 국소용 코-엔자임 큐10 제형 및 그의 사용 방법 |
| EP2136831B1 (en) | 2007-03-02 | 2012-09-12 | The Cleveland Clinic Foundation | Anti-angiogenic peptides |
| CA2705152C (en) | 2007-11-09 | 2016-10-11 | Peregrine Pharmaceuticals, Inc. | Anti-vegf antibody compositions and methods |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| GB2543498A (en) * | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
| CN107174584B (zh) * | 2016-03-12 | 2020-09-01 | 福建金乐医药科技有限公司 | 含哌嗪结构化合物在制备lsd1抑制剂中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2931741A1 (de) * | 1979-08-04 | 1981-02-26 | Thomae Gmbh Dr K | Arzneimittel zur vermeidung von tumormetastierung |
| JPS6038384B2 (ja) * | 1978-03-24 | 1985-08-31 | 大塚製薬株式会社 | チオセミカルバゾン誘導体 |
| JPS5742673A (en) * | 1980-08-29 | 1982-03-10 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS5883677A (ja) * | 1981-11-11 | 1983-05-19 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| JPS5929667A (ja) * | 1982-08-13 | 1984-02-16 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体および強心剤 |
| JPS59104378A (ja) * | 1982-12-03 | 1984-06-16 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| US4582909A (en) * | 1984-02-02 | 1986-04-15 | Warner-Lambert Company | Benzobicyclic lactam acids and derivatives as cognition activators |
| US4677112A (en) * | 1984-02-02 | 1987-06-30 | Warner-Lambert Company | 1,2,3,4-tetrahydro-2-oxo-8-quinolineacetic and -propanoic acids and derivatives as cognition activators |
| JPH07100696B2 (ja) * | 1984-12-18 | 1995-11-01 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| US4760064A (en) * | 1984-12-18 | 1988-07-26 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds, compositions containing same and processes for preparing same |
| DE3526044A1 (de) * | 1985-07-20 | 1987-01-22 | Hoechst Ag | Dihydrochinolinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung, sowie zwischenprodukte zu ihrer herstellung |
| DK588486A (da) * | 1985-12-09 | 1987-06-10 | Otsuka Pharma Co Ltd | Anvendelse af en forbindelse til behandling af hypoxi |
| JPS62135423A (ja) * | 1985-12-09 | 1987-06-18 | Otsuka Pharmaceut Co Ltd | 低酸素症改善剤 |
| JPS63225357A (ja) * | 1987-03-12 | 1988-09-20 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
| US5185346A (en) * | 1988-11-29 | 1993-02-09 | Hanssen Pharmaceutica | (1H-azol-1-ylmethyl)substituted quinoline derivatives |
| TW201305B (OSRAM) * | 1991-04-03 | 1993-03-01 | Otsuka Pharma Co Ltd | |
| DK0552373T3 (da) * | 1991-07-03 | 1999-12-27 | Otsuka Pharma Co Ltd | Apoptoseregulator |
| JPH05320133A (ja) * | 1991-07-18 | 1993-12-03 | Japan Tobacco Inc | ３，４−ジヒドロ−２（１ｈ）−キノリノン誘導体 |
| JP2597953B2 (ja) * | 1991-12-10 | 1997-04-09 | 大塚製薬株式会社 | 制癌剤 |
| JPH0612248A (ja) * | 1992-04-02 | 1994-01-21 | Hitachi Ltd | プログラムの自動生成方式 |
-
1993
- 1993-08-12 WO PCT/JP1993/001144 patent/WO1994004504A1/ja not_active Ceased
- 1993-08-12 EP EP94908099A patent/EP0623598A4/en not_active Withdrawn
- 1993-08-12 CA CA002121148A patent/CA2121148A1/en not_active Abandoned
- 1993-08-12 AU AU47615/93A patent/AU666577B2/en not_active Ceased
- 1993-08-12 US US08/211,818 patent/US5464833A/en not_active Expired - Fee Related
- 1993-08-18 TW TW082106642A patent/TW240168B/zh active
- 1993-08-18 PH PH46711A patent/PH30152A/en unknown
- 1993-08-19 MX MX9305056A patent/MX9305056A/es unknown
-
1995
- 1995-08-29 US US08/520,478 patent/US5691341A/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2121148A1 (en) | 1994-03-03 |
| PH30152A (en) | 1997-01-21 |
| US5464833A (en) | 1995-11-07 |
| EP0623598A1 (en) | 1994-11-09 |
| MX9305056A (es) | 1994-04-29 |
| AU666577B2 (en) | 1996-02-15 |
| AU4761593A (en) | 1994-03-15 |
| WO1994004504A1 (fr) | 1994-03-03 |
| US5691341A (en) | 1997-11-25 |
| EP0623598A4 (en) | 1997-05-02 |